Preoperative therapy with pazopanib in high-risk soft tissue sarcoma: a phase II window-of-opportunity study by the German Interdisciplinary Sarcoma Group (GISG-04/NOPASS)

INTRODUCTION: For resectable soft tissue sarcoma (STS), radical surgery, usually combined with radiotherapy, is the mainstay of treatment and the only potentially curative modality. Since surgery is often complicated by large tumour size and extensive tumour vasculature, preoperative treatment strat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ronellenfitsch, Ulrich, Dimitrakopoulou-Strauss, Antonia, Jakob, Jens, Kasper, Bernd, Nowak, Kai, Pilz, Lothar R, Attenberger, Ulrike, Gaiser, Timo, Egerer, Gerlinde, Fröhling, Stefan, Derigs, Hans-Günter, Schwarzbach, Matthias, Hohenberger, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716254/
https://www.ncbi.nlm.nih.gov/pubmed/26739732
http://dx.doi.org/10.1136/bmjopen-2015-009558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716254/
https://www.ncbi.nlm.nih.gov/pubmed/26739732
http://dx.doi.org/10.1136/bmjopen-2015-009558

Ejemplares similares